{{Infobox Company |
  company_name   = Alcon, Inc.|
  company_logo   = [[Image:Logo_Alcon.svg|250px]] |
  company_type   = [[上市公司|上市公司]] |
  traded_as      =   {{unbulleted list|{{SWX|ALC}}|{{New York Stock Exchange|ALC}}}} |
  fate           =  |
  foundation     = {{USA}}[[沃思堡|沃思堡]]（1945）|
  defunct        = {{End date|2010}}|
  location       = {{SWI}}[[休倫堡|休倫堡]]<br />{{USA}}[[沃思堡|沃思堡]] |
  key_people     = David Endicott（CEO） |
  industry       = [[眼科|眼科]] |
  products       =      眼科製藥<br />[[手術儀器|手術儀器]]<br />[[隱形眼鏡|隱形眼鏡]] |
  revenue        = {{profit}} $100億 [[美元|美元]] (2011) |
  num_employees  = 23,000+ (2011) |
  homepage       = [http://www.alcon.com/ http://www.alcon.com/]
}}
'''愛爾康'''（'''Alcon'''）是一家跨國製藥公司，總部在[[瑞士|瑞士]][[休倫堡|休倫堡]]，美國總部位於[[沃思堡|沃思堡]]，此處同時也是其創始地。

==历史==
1945年两名药剂师Robert Alexander和William Conner在德州[[沃思堡|沃思堡]]开了一家药店，将他们姓氏开头两个音节组成药店名'''Alcon'''。1977年，公司被[[雀巢|雀巢]]买下。<ref>{{Cite web|title=Novartis to Buy Majority of Alcon From Nestlé|url=https://dealbook.nytimes.com/2010/01/04/novartis-buys-majority-of-alcon-from-nestle/|last=Nicholson|first=Chris|date=4 January 2010|website=The New York Times|archive-url=https://web.archive.org/web/20140106103838/https://dealbook.nytimes.com/2010/01/04/novartis-buys-majority-of-alcon-from-nestle/|archive-date=2014-01}}</ref>

2008年4月，[[諾華|諾華]]斥資104億美元向雀巢收購愛爾康约25%的股权，至2010年完全收購愛爾康。 <ref name="scribd.com">{{Cite web |url=http://www.scribd.com/doc/24764035/Novartis-exercises-option-and-proposes-merger |title=Scribd - Novartis exercises option and proposes merger |accessdate=2014-04-23 |archive-date=2014-02-02 |archive-url=https://web.archive.org/web/20140202173318/http://www.scribd.com/doc/24764035/Novartis-exercises-option-and-proposes-merger |dead-url=no }}</ref>

2019年4月9日，愛爾康从诺华独立，在[[瑞士證券交易所|瑞士證券交易所]]和[[紐約證券交易所|紐約證券交易所]]上市交易<ref>{{Cite web|url=http://www.pharmatimes.com/news/novartis_continues_to_reimagine_itself,_as_alcon_spin-off_completed_1284192|title=Novartis continues to ‘reimagine’ itself, as Alcon spin-off completed|last=Smith|first=Anna|date=2019-04-10|website=PharmaTimes|language=en|access-date=2019-04-10|archive-date=2020-11-28|archive-url=https://web.archive.org/web/20201128013754/http://www.pharmatimes.com/news/novartis_continues_to_reimagine_itself,_as_alcon_spin-off_completed_1284192|dead-url=no}}</ref><ref>{{Cite news|url=https://uk.reuters.com/article/uk-alcon-spinoff-idUKKCN1RL0KH|title=Alcon tops $28 billion market cap in decade's biggest Swiss stock deal|date=2019-04-09|work=Reuters|access-date=2019-04-10|language=en|archive-date=2020-12-05|archive-url=https://web.archive.org/web/20201205124532/https://uk.reuters.com/article/uk-alcon-spinoff-idUKKCN1RL0KH|dead-url=no}}</ref><ref>{{Cite web|url=https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bdd896d04-7421-4015-ad2d-9c1213d06040%7D/novartis-completes-alcon-spin-off|title=Novartis completes Alcon spin-off|last=April 9|last2=2019|website=www.healio.com|language=en|access-date=2020-02-25|archive-date=2019-07-30|archive-url=https://web.archive.org/web/20190730112342/https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7Bdd896d04-7421-4015-ad2d-9c1213d06040%7D/novartis-completes-alcon-spin-off|dead-url=no}}</ref>，新公司市值达280亿瑞士法郎。<ref>{{Cite web|url=http://www.pharmatimes.com/news/novartis_continues_to_reimagine_itself,_as_alcon_spin-off_completed_1284192|title=Novartis continues to ‘reimagine’ itself, as Alcon spin-off completed|last=Smith|first=Anna|date=2019-04-10|website=PharmaTimes|language=en|access-date=2020-01-30|archive-date=2020-11-28|archive-url=https://web.archive.org/web/20201128013754/http://www.pharmatimes.com/news/novartis_continues_to_reimagine_itself,_as_alcon_spin-off_completed_1284192|dead-url=no}}</ref>

==參考文獻==
{{reflist}}

==外部链接==
* [https://www.alcon.com/  官方网站（美国）] {{Wayback|url=https://www.alcon.com/ |date=20210316090626 }}
* [https://www.alcon.com.cn/zh-hans  官方网站（中国）] {{Wayback|url=https://www.alcon.com.cn/zh-hans |date=20210117132020 }}
* [https://www.alcon.com.tw/zh-hant  官方网站（台灣）] {{Wayback|url=https://www.alcon.com.tw/zh-hant |date=20210122150410 }}
*[http://www.scribd.com/doc/24764035/Novartis-exercises-option-and-proposes-merger/ Alcon : Novartis exercises option and proposes merger] {{Wayback|url=http://www.scribd.com/doc/24764035/Novartis-exercises-option-and-proposes-merger/ |date=20140202173318 }}
*[http://www.reuters.com/article/idUSLDE65R0EZ20100628/ Novartis needs Alcon directors' OK for buyout]
*[http://www.transactioninfo.com/alcon/docs/Alcon_Release_6_28_10.pdf/ Swiss Corporate Governance Expert Supports Alcon Independent Director Committee’s Position against Novartis]{{dead link|date=2017年12月 |bot=InternetArchiveBot |fix-attempted=yes }}

{{瑞士市场指数上市公司}}
[[Category:瑞士公司|Category:瑞士公司]]
[[Category:跨國公司|Category:跨國公司]]
[[Category:隐形眼镜|Category:隐形眼镜]]
[[Category:美國製藥公司|Category:美國製藥公司]]
[[Category:紐約證券交易所已除牌公司|Category:紐約證券交易所已除牌公司]]